Photo Release: The Department of Disease Control (DDC), the Ministry of Public Health,

Food and Healthcare Press Releases Friday December 1, 2017 15:46
Bangkok--1 Dec--4D Communications

SOFFELL Enesis Group and Dr. Prawit Wairungruangkul (4th person from left), Managing Director of CP Consumer Products Co., Ltd., together with the company's executives gave Soffell mosquito repellents, value at 1,728,000 baht in total, to the Department of Disease Control, Ministry of Public Health. The products would be delivered to mobile health units to be given out to people in areas prone to dengue fever and Zika fever, both of which have mosquitos as vectors. Dr. Panumat Yannawetsakul (4th person from right), Deputy Director of the Department of Disease Control, received the gifts on behalf of the department. This preventive healthcare activity is one of the social activities that Soffell has been continuously doing.


Latest Press Release

Israel Ministry of Health Includes INSIGHTEC#s Focused Ultrasound Treatment for Medication-Refractory Essential Tremor as Part of Covered Health Services

INSIGHTEC(R), a commercial-stage medical technology company revolutionizing surgery with incisionless MR-guided focused ultrasound (MRgFUS) announced today that the Neuravive focused ultrasound treatment will be a covered service for essential tremor...

The ImplantCenter Marks a New Era in the Hungarian Private Dental Service

The ImplantCenter has recently opened the brand-new operating room suited for more complex treatments. This comes alongside numerous additions such as the launch of the four cosy apartments to rest after treatments at the clinic and an implant education...

Merck and Pfizer Provide Update on Phase III JAVELIN Lung 200 Trial of Avelumab Monotherapy in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer

Merck and Pfizer Inc. (NYSE: PFE) today announced results from the Phase III JAVELIN Lung 200 trial comparing avelumab* to docetaxel in patients with unresectable, recurrent or metastatic non-small cell lung cancer (NSCLC) whose disease progressed after...

PharmaMar Licenses Fully Synthetic Marine-derived Payloads to Seattle Genetics for Use in Drug Conjugates

PharmaMar (MCE: PHM) has announced today the signing of an exclusive licensing agreement with Seattle Genetics Inc. (SGEN: NASDAQ GS) under which Seattle Genetics receives exclusive worldwide rights to certain PharmaMar proprietary molecules for the...

After multiple failed procedures at other medical institutions, Colorado man successfully treated for Atrial Fibrillation at Texas Cardiac Arrhythmia Institute at St. David#s Medical Center

"I was thinking I was on top of the world," Wiseman said. "I was keeping myself in shape. I was taking care of myself mentally and physically. My relationship was solid." Then, during a routine medical exam while serving in the military in California,...

Related Topics